TICKERNERD
Menu
NVSTNVSTHealthcare · Medical Instruments & Supplies

NVST Stock Forecast: Envista Holdings Corp. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$28
−0.04% on the day

The 16 Wall Street analysts covering Envista Holdings Corp. hold a median 12-month price target of $31 — +8.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 99 of 100 as at 15 Aug 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$4.5B
Ticker Nerd rank
99 / 100
Median analyst target
$31
Analysts covering
16
Total return, dividends reinvested
1W
−0.3%
1M
+7.5%
YTD
+29.3%
1Y
+34.8%
From 52W high
−7.2%
From 52W low
+48.1%
$19
$30
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

NVST stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Envista Holdings Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Aug 2026
99 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
96
Value
96
Volatility
87
Issuance
85
Momentum
75
Growth
73
Accruals
70
Quality
70
Size
25

Revisions (96): Analysts have, on balance, been raising their forecasts.

Quality (70): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Size (25): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

NVST stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NVST, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$20$25$30$35Oct 25Jan 26Apr 26Jul 26NVSTHigh $35Median $31Low $23

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says16 analysts
7 Buy9 Hold0 Sell
Low $23Median $31High $35

The green dot is the last close — the median target sits +8.7% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
6 Aug 2026Piper SandlerReiteratesNeutral$26 → $28
29 July 2026Piper SandlerMaintainsNeutral$25 → $26
29 July 2026Piper SandlerMaintainsNeutral—
9 July 2026BMO CapitalInitiatesMarket Perform—
9 July 2026BMO CapitalInitiatesMarket Perform$27
11 June 2026BarclaysMaintainsOverweight—
7 May 2026BairdMaintainsOutperform—
7 May 2026Evercore ISI GroupMaintainsOutperform—
7 May 2026JP MorganMaintainsNeutral—
24 Apr 2026Morgan StanleyMaintainsEqual-Weight—
15 Apr 2026CitigroupInitiatesNeutral—
8 Apr 2026Evercore ISI GroupMaintainsOutperform—
11 Feb 2026BarclaysMaintainsOverweight—
10 Feb 2026MizuhoMaintainsNeutral—
6 Feb 2026JP MorganMaintainsNeutral—
6 Feb 2026Piper SandlerReiteratesNeutral—
6 Feb 2026StifelMaintainsBuy—
6 Feb 2026Wells FargoMaintainsEqual-Weight—
4 Feb 2026StifelMaintainsBuy—
3 Feb 2026UBSMaintainsNeutral—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NVST appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

NVST analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+7.2%
Analysts raising
2
Analysts cutting
0
Fundamentals

Envista Holdings Corp. (NVST) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
48.4×

Cheaper than 16% of US stocks

Price / sales
1.6×

Cheaper than 59% of US stocks

Price / book
1.5×

Cheaper than 57% of US stocks

EV / EBITDA
11.9×

Cheaper than 33% of US stocks

Growth & margins
Revenue growth (YoY)
7.1%

Higher than 45% of US stocks

Earnings growth (YoY)
103.4%

Higher than 85% of US stocks

Gross margin
55.7%

Higher than 69% of US stocks

Operating margin
12.1%

Higher than 68% of US stocks

Net margin
3.3%

Higher than 56% of US stocks

Returns & dividend
Return on equity
3.1%

Higher than 50% of US stocks

Return on assets
3.4%

Higher than 67% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

NVST vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
NVSTEnvista Holdings Corp.$4.5B
99
ICUIICU Medical, Inc.$4.5B
96
MMSIMerit Medical Systems, Inc.$5.4B
90
MMEDMiniMed Group, Inc.$5.7B
2
STVNStevanato Group SpA$5.7B
64
TFXTeleflex, Inc.$6.1B
82
BLCOBausch + Lomb Corp.$6.1B
86

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Envista Holdings Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest NVST news & analysis

Can NVST Sustain Its 2026 Guidance Boost as Margins Keep Expanding?

Zacks Investment Research · 14 Aug 2026neutral

Envista Holdings raised its 2026 guidance, citing stronger sales, expanding margins, and higher earnings. The report also flags potential headwinds including China pricing pressures, tariffs, and a tougher fourth quarter.

Why it matters — NVST watchers would follow this because the improved outlook signals earnings strength even as China pricing, tariffs, and Q4 conditions could challenge how well the company sustains the boost.

Is NVST a Buy as Earnings Rebound but Valuation Remains Above Median?

Zacks Investment Research · 13 Aug 2026neutral

Zacks reported that Envista's earnings have rebounded and the company raised its 2026 guidance, though its valuation remains above the median, leaving less room for execution missteps.

Why it matters — NVST watchers would care because the earnings recovery and guidance raise are positive signals, but the above-median valuation means the stock may be more vulnerable to any operational setbacks.

4 Best PEG-Driven Value Stocks to Buy Now for Strong Returns

Zacks Investment Research · 10 Aug 2026positive

A Zacks Investment Research article highlights four value stocks selected for low PEG ratios, strong earnings growth prospects, and favorable value scores, positioning them as potential options beyond traditional P/E-based screening.

Why it matters — The piece draws attention to value-oriented names like those covered on the NVST page, giving watchers context on how such stocks are being screened for valuation and growth.

Best Momentum Stocks to Buy for August 10th

Zacks Investment Research · 10 Aug 2026positive

Envista Holdings Corp. (NVST) was included in Zacks Investment Research's list of top momentum stocks to buy, receiving a Zacks Rank #1 (Strong Buy) designation as of August 10, 2026.

Why it matters — Inclusion in the Zacks Rank #1 (Strong Buy) momentum stocks list signals that NVST is viewed favorably by the research firm based on momentum factors.

Investing in Envista (NVST)? Don't Miss Assessing Its International Revenue Trends

Zacks Investment Research · 10 Aug 2026neutral

Zacks Investment Research published an item examining the evolution of Envista's (NVST) overseas revenue trends. The piece looks at how these international revenue patterns affect Wall Street's forecasts for the company and its stock's prospects.

Why it matters — A NVST watcher would care because shifts in international revenue trends can influence analyst forecasts and the company's stock outlook.

FAQ

Frequently asked questions about NVST stock

What is the NVST stock price forecast for 2026-2027?

The 16 Wall Street analysts covering Envista Holdings Corp. have a median 12-month price target of $31, with estimates ranging from $23 to $35. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is NVST stock a buy right now?

Of the 16 analysts covering Envista Holdings Corp., 7 rate it a Buy, 9 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Envista Holdings Corp. 99 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank NVST?

As at 15 Aug 2026, Envista Holdings Corp. ranks 99 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (96 of 100).

Will NVST stock go up?

No one can know that. What the data says: the median 12-month target from 16 analysts implies +8.7% from the last close, and Ticker Nerd's factor model ranks Envista Holdings Corp. 99 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the NVST stock forecast for 2030?

No analyst covering Envista Holdings Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NVST are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $23 to $35 over the next 12 months.

How has NVST stock performed over the past year?

Envista Holdings Corp. returned +34.8% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Envista Holdings Corp. do?

Envista Holdings Corporation is a global leader in developing, manufacturing, and marketing a wide range of dental equipment and technology. Operating primarily within the dental industry, the company serves dental professionals with innovative products and solutions.

What is the latest news on NVST?

The most recent item we track (Zacks Investment Research, 14 Aug 2026): "Can NVST Sustain Its 2026 Guidance Boost as Margins Keep Expanding?". Envista Holdings raised its 2026 guidance, citing stronger sales, expanding margins, and higher earnings. The report also flags potential headwinds including China pricing pressures, tariffs, and a tougher fourth quarter.

Company

About Envista Holdings Corp.

Envista Holdings Corporation is a global leader in developing, manufacturing, and marketing a wide range of dental equipment and technology. Operating primarily within the dental industry, the company serves dental professionals with innovative products and solutions. Envista is particularly well-known for its comprehensive offerings in dental consumables, orthodontic appliances, and imaging equipment, which are essential tools for modern dental practices and laboratories. The corporation plays a crucial role in enhancing dental care quality by providing cutting-edge technology and promoting digital dentistry. Envista supports various sectors within dentistry, including preventive care, implantology, and orthodontics, making it integral to dental health professionals worldwide. With a commitment to research and development, Envista continuously brings advancements to the dental market, fostering improved patient outcomes and efficiency in dental services. As a significant industry player, Envista Holdings Corporation contributes to setting benchmarks for innovation and technology integration in healthcare, positioning itself as a key entity in the global dental market landscape.

CEO Mr. Paul A. Keel · 12,000 employees · United States · https://envistaco.com